scholarly article | Q13442814 |
P50 | author | Antonio Waldo Zuardi | Q60324489 |
José A Crippa | Q64857123 | ||
Jaime Eduardo Cecilio Hallak | Q89090861 | ||
Roger B Varela | Q98181239 | ||
Daniela V Bavaresco | Q98937455 | ||
João Quevedo | Q42644849 | ||
Giselli Scaini | Q42968861 | ||
Emilio L Streck | Q42968871 | ||
P2093 | author name string | Samira S Valvassori | |
Marcos H Chagas | |||
P2860 | cites work | The GRACILE syndrome, a neonatal lethal metabolic disorder with iron overload | Q43672303 |
Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy | Q43737909 | ||
Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells | Q44804966 | ||
Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease | Q46443478 | ||
Brain creatine kinase activity in an animal model of mania | Q46811362 | ||
Creatine supplementation affords cytoprotection in oxidatively injured cultured mammalian cells via direct antioxidant activity | Q46977833 | ||
Immunoelectron microscopic investigation of creatine kinase BB-isoenzyme after cerebral ischemia in gerbils | Q48376156 | ||
Abnormal properties of creatine kinase in Alzheimer's disease brain: correlation of reduced enzyme activity and active site photolabeling with aberrant cytosol-membrane partitioning | Q48471962 | ||
Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. | Q55032889 | ||
Pharmacological and therapeutic targets for ?9 tetrahydrocannabinol and cannabidiol | Q55931493 | ||
GRACILE syndrome, a lethal metabolic disorder with iron overload, is caused by a point mutation in BCS1L | Q24617140 | ||
Effects of creatine on mental fatigue and cerebral hemoglobin oxygenation | Q28216292 | ||
Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research | Q30995022 | ||
Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma | Q31149457 | ||
N-acetyl aspartate: a marker for neuronal loss or mitochondrial dysfunction | Q31997000 | ||
Genomic and proteomic analysis of the effects of cannabinoids on normal human astrocytes | Q33652502 | ||
Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug | Q33995048 | ||
Cannabidiol--recent advances | Q34005880 | ||
Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists | Q34103173 | ||
Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects | Q34253509 | ||
Neural mechanisms for the cannabinoid modulation of cognition and affect in man: a critical review of neuroimaging studies | Q34310759 | ||
Functional aspects of creatine kinase in brain. | Q34314804 | ||
Mitochondria and degenerative disorders | Q34386737 | ||
Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. | Q34602111 | ||
Cannabinoid receptors and their ligands | Q34673022 | ||
Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death? | Q35968596 | ||
Functions and effects of creatine in the central nervous system. | Q37172733 | ||
Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action | Q37285921 | ||
Structure and organization of mitochondrial respiratory complexes: a new understanding of an old subject | Q37594110 | ||
Mitochondria as sensors and regulators of calcium signalling | Q38031124 | ||
Respiratory chain complex II as general sensor for apoptosis | Q38045648 | ||
Differential effects of creatine depletion on the regulation of enzyme activities and on creatine-stimulated mitochondrial respiration in skeletal muscle, heart, and brain | Q38561941 | ||
Cannabidiol targets mitochondria to regulate intracellular Ca2+ levels. | Q39881941 | ||
Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death | Q40069054 | ||
Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement | Q40313822 | ||
Delta 9-tetrahydrocannabinol disrupts mitochondrial function and cell energetics | Q40676646 | ||
Mitochondrial heterogeneity in the brain at the cellular level | Q41719646 | ||
Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania | Q43235417 | ||
P433 | issue | 4 | |
P921 | main subject | cannabidiol | Q422917 |
cannabinoids | Q422936 | ||
P304 | page(s) | 380-386 | |
P577 | publication date | 2013-10-01 | |
P1433 | published in | Brazilian Journal of Psychiatry | Q7318477 |
P1476 | title | Acute and chronic administration of cannabidiol increases mitochondrial complex and creatine kinase activity in the rat brain | |
P478 | volume | 35 |
Q38598487 | An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies |
Q97428443 | Cannabidiol and Sports Performance: a Narrative Review of Relevant Evidence and Recommendations for Future Research |
Q55387906 | Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders? |
Q37595135 | Cannabidiol attenuates OGD/R-induced damage by enhancing mitochondrial bioenergetics and modulating glucose metabolism via pentose-phosphate pathway in hippocampal neurons |
Q38828985 | Evidences for the Anti-panic Actions of Cannabidiol |
Q36157649 | Molecular Targets of Cannabidiol in Neurological Disorders |
Q60047511 | Morphine Binds Creatine Kinase B and Inhibits Its Activity |
Q48596972 | The adenosine salvage pathway as an alternative to mitochondrial production of ATP in maturing mammalian oocytes |
Q57300019 | Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age |
Search more.